$Recro Pharma(REPH)$ 内部交易: 2016-05-19,Director,Weisman Wayne ,卖出,5000普通股, $6.46
$Recro Pharma(REPH)$ 内部交易: 2016-11-30,Director,Weisman Wayne ,卖出,600普通股, $9.00
$Recro Pharma(REPH)$ 内部交易: 2016-11-27,Director,Weisman Wayne ,卖出,8987普通股, $9.00
$Recro Pharma(REPH)$ 内部交易: 2016-11-25,Director,Weisman Wayne ,卖出,6201普通股, $9.00
$Recro Pharma(REPH)$ 内部交易: 2016-11-24,Director,Weisman Wayne ,卖出,2759普通股, $9.01
$Recro Pharma(REPH)$ 内部交易: 2016-11-23,Director,Weisman Wayne ,卖出,14784普通股, $9.00
$Recro Pharma(REPH)$ 8-K - Current report Filed: 2016-05-12 AccNo: 0001193125-16-588240 Size: 22 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-12 AccNo: 0001193125-16-588250 Size: 3 MB 网页链接
$Recro Pharma(REPH)$ 8-K/A [Amend] - Current report Filed: 2016-04-29 AccNo: 0001193125-16-567431 Size: 98 KBItem 9.01: Financial Statements and Exhibits 网页链接
$Recro Pharma(REPH)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-14 AccNo: 0001193125-16-541602 Size: 520 KB 网页链接